Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Systemic Inflammation to Concurrently Treat Late-Life Depression and Reduce Coronary Artery Disease Risk

NCT01625845 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT01625845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01625845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Systemic Inflammation to Concurrently Treat Late-Life Depression and Reduce Coronary Artery Disease Risk
Lead sponsor
Indiana University
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2012
Completion date
May 31, 2014
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease (cvd), coronary artery disease (cad), depression, depressive symptoms, heart disease, major depressive disorder